Health Canada Issues Recalls of Sandoz`s Lisinopril tablet
08 Oct 2025 //
HEALTH CANADA
Prothya Biosolutions Netherlands B.V.`s Fails EDQM inspection
08 Oct 2025 //
EMA
Enforcement Report - Week of October 8, 2025
08 Oct 2025 //
FDA
FDA Issues Form 483 to Aurobindo Pharmaceuticals
03 Oct 2025 //
FDA
Enforcement Report - Week of October 1, 2025.pdf
01 Oct 2025 //
FDA
FDA Issues Form 483 to Dr. Reddy Lab
01 Oct 2025 //
FDA
Persōn & Covey Recieves Warning Letter
30 Sep 2025 //
FDA
Sichuan Savory Biotechnology is on FDA Import Alert List
26 Sep 2025 //
FDA
Guangxi Yulin Pharmaceutical is on FDA Import Alert List
26 Sep 2025 //
FDA
Exela Pharma Sciences is on Health Canada Inspection List
25 Sep 2025 //
HEALTH CANADA
Amneal Pharmaceuticals is on Health Canada Inspection List
25 Sep 2025 //
HEALTH CANADA
Glenmark Pharma is on Health Canada Inspection List
25 Sep 2025 //
HEALTH CANADA
Shiva Analyticals is on Health Canada Inspection List
25 Sep 2025 //
HEALTH CANADA
Wisconsin Pharmacal is on Health Canada Inspection List
25 Sep 2025 //
HEALTH CANADA
Veyx-Pharma`s Fails EDQM inspection
25 Sep 2025 //
EMA
Produlab Pharma Production B.V`s Fails EDQM inspection
25 Sep 2025 //
EMA
Produlab Pharma B.V`s Fails EDQM inspection
25 Sep 2025 //
EMA
Johnson & Johnson Recieves Warning Letter
24 Sep 2025 //
FDA
Enforcement Report - Week of September 24, 2025
24 Sep 2025 //
FDA
Chengdu Brilliant Biopharmaceutical Recieves Warning Letter
23 Sep 2025 //
FDA
FDA Issues Form 483 to Nephron Pharmaceuticals
22 Sep 2025 //
FDA
Taizhou Kangping Medical Science is on FDA Import Alert List
18 Sep 2025 //
FDA
Seema International is on FDA Import Alert List
18 Sep 2025 //
FDA
Enforcement Report - Week of September 17, 2025
17 Sep 2025 //
FDA
FDA Issues Form 483 to Olympia Pharmaceuticals
12 Sep 2025 //
FDA
Mera Cannabis Corp.`s Fails EDQM inspection
11 Sep 2025 //
EMA
Ilko Ilac Sanayi Ve Ticaret A.S`s Fails EDQM inspection
10 Sep 2025 //
EMA
Enforcement Report - Week of September 10, 2025
10 Sep 2025 //
FDA
Hikal Limited Recieves Warning Letter
09 Sep 2025 //
FDA
FDA Issues Form 483 to GenoGenix
04 Sep 2025 //
FDA
Enforcement Report - Week of September 3, 2025
03 Sep 2025 //
FDA
FDA Issues Form 483 to AnazaoHealth Corporation
02 Sep 2025 //
FDA
Amneal Pharmaceuticals Recieves Warning Letter
02 Sep 2025 //
FDA
Wisconsin Pharmacal Recieves Warning Letter
02 Sep 2025 //
FDA
Green Lumber Alerts Consumers on Counterfeits After FDA Findings
29 Aug 2025 //
FDA
DermaRite Expands Nationwide Recall Over Burkholderia Cepacia
28 Aug 2025 //
FDA
FDA Issues Form 483 to IntegraDose Compounding Services
28 Aug 2025 //
FDA
Enforcement Report - Week of August 27, 2025
27 Aug 2025 //
FDA
Unichem Issues Voluntary Nationwide Recalls of Cyclobenzaprine
27 Aug 2025 //
FDA
FDA Issues Form 483 to Hikma Injectables USA
27 Aug 2025 //
FDA
Yangzhou Yulou is on FDA Import Alert List
26 Aug 2025 //
FDA
Platinum Biologics Recieves Warning Letter
26 Aug 2025 //
FDA
Enforcement Report - Week of August 20, 2025
20 Aug 2025 //
FDA
B. Braun Issues Voluntary Nationwide Recall of Ringer’s Injection
19 Aug 2025 //
FDA
Anhui Hanbon Daily Chemical Co. Recieves Warning Letter
19 Aug 2025 //
FDA
Enforcement Report - Week of August 13, 2025
13 Aug 2025 //
FDA
Gussyup Private Label Grooming Recieves Warning Letter
12 Aug 2025 //
FDA
DermaRite Issues a Nationwide Recall of DermaKleen, Dermasarra
12 Aug 2025 //
FDA
FDA Issues Form 483 to QuVa Pharma
12 Aug 2025 //
FDA
FDA Issues Form 483 to Stokes Healthcare dba Epicur Pharma
08 Aug 2025 //
FDA
FDA Issues Form 483 to Medi-Fare Drug Pharmaceutical
07 Aug 2025 //
FDA
Enforcement Report - Week of August 6, 2025
06 Aug 2025 //
FDA
Oasis Medical Recieves Warning Letter
05 Aug 2025 //
FDA
Enforcement Report - Week of July 30, 2025
30 Jul 2025 //
FDA
Shiva Analyticals Recieves Warning Letter
29 Jul 2025 //
FDA
Kabana Skin Recieves Warning Letter
29 Jul 2025 //
FDA
Macsen Drug Recieves Warning Letter
29 Jul 2025 //
FDA
Glenmark Pharmaceuticals Recieves Warning Letter
22 Jul 2025 //
FDA
Medical Chemical Corporation Recieves Warning Letter
22 Jul 2025 //
FDA
Nature’s Fusions LLC Recieves Warning Letter
22 Jul 2025 //
FDA